BDX vs. ABT, ISRG, SYK, BSX, MDT, EW, RMD, IDXX, DXCM, and STE
Should you be buying Becton, Dickinson and Company stock or one of its competitors? The main competitors of Becton, Dickinson and Company include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Becton, Dickinson and Company vs.
Abbott Laboratories (NYSE:ABT) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.
In the previous week, Abbott Laboratories had 17 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 45 mentions for Abbott Laboratories and 28 mentions for Becton, Dickinson and Company. Abbott Laboratories' average media sentiment score of 1.50 beat Becton, Dickinson and Company's score of 1.41 indicating that Abbott Laboratories is being referred to more favorably in the media.
Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 1.9%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 1.9%. Abbott Laboratories pays out 66.9% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 70.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Abbott Laboratories has increased its dividend for 53 consecutive years and Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Abbott Laboratories is clearly the better dividend stock, given its higher yield and lower payout ratio.
Abbott Laboratories has higher revenue and earnings than Becton, Dickinson and Company. Abbott Laboratories is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.
Abbott Laboratories received 337 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 69.70% of users gave Abbott Laboratories an outperform vote while only 62.38% of users gave Becton, Dickinson and Company an outperform vote.
75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by insiders. Comparatively, 0.3% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Abbott Laboratories has a net margin of 13.99% compared to Becton, Dickinson and Company's net margin of 8.55%. Abbott Laboratories' return on equity of 20.18% beat Becton, Dickinson and Company's return on equity.
Abbott Laboratories has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.
Abbott Laboratories currently has a consensus price target of $130.07, indicating a potential upside of 12.19%. Becton, Dickinson and Company has a consensus price target of $283.00, indicating a potential upside of 27.25%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Abbott Laboratories.
Summary
Abbott Laboratories beats Becton, Dickinson and Company on 15 of the 20 factors compared between the two stocks.
Get Becton, Dickinson and Company News Delivered to You Automatically
Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Becton, Dickinson and Company Competitors List
Related Companies and Tools
This page (NYSE:BDX) was last updated on 11/21/2024 by MarketBeat.com Staff
